Abstract
Chagas disease (CD) is an anthropozoonosis caused by Trypanosoma cruzi (T. cruzi) and can appear as an opportunistic infection in HIV-infected patients, especially in endemic Latin-American countries, but also in non-endemic regions, where its diagnosis is more challenging. The central nervous system (CNS) is most commonly affected during reactivation, and expansive lesions are commonly observed in AIDS patients. The diagnosis of CD reactivation in HIV patients requires a high suspicion. Serological tests are required to diagnose CD but are insufficient to confirm reactivation, which is characterized by high levels of parasite replication and parasitemia, usually detected by microscopy. The identification of trypomastigotes in the CNS is criteria sufficient for the definitive diagnosis of chagasic encephalitis. Treatment follows standard recommendations (benznidazole or nifurtimox), and initiation/optimization of anti-retroviral therapy must be carefully considered. Mortality is high for symptomatic reactivated T. cruzi infection, even in patients who receive chemotherapy. Data suggest that early recognition and treatment of reactivation may improve prognosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Kirchhoff LV, Weiss LM, Wittner M, Tanowitz HB (2004) Parasitic diseases of the heart. Front Biosci 9:706–723
Ferreira MS, Borges AS (2002) Some aspects of protozoan infections in immunocompromised patients. A review. Mem Inst Oswaldo Cruz 97:443–457
Almeida EA, Ramos Jr AN, Correia D, Shikanai-Yasuda MA (2009) Brazilian network of attention and studies on Trypanosoma cruzi/HIV co-infection and others immunosuppression conditions. Rev Soc Bras Med Trop 42:605–608
Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Downloaded from http://aidsinfo.nih.gov/guidelines on 21 Sept 2016
Pan American Health Organization. http://www.paho.org/world-health-day-2014/wp-content/uploads/2014/04/Chagas.pdf. Accessed in Aug 2016
Strasen J, Williams T, Ertl G, Zoller T, Stich A, Ritter O (2014) Epidemiology of CD in Europe: many calculations, little knowledge. Clin Res Cardiol 103(1):1–10
World Health Organization, www.who.int. Accessed in Aug 2016
http://www.cdc.gov/parasites/chagas/. Accessed in Aug 2016
Requena-Méndez A et al (2014) Health policies to control Chagas disease transmission in European countries. PLoS Negl Trop Dis 8(10):e3245
Spina-França A, Livramento JA, Machado LR, Yassuda N (1988) Anticorpos anti Trypanosoma cruzi no líquido cefalorraqueano: pesquisa pelas reações de fixação do complemento e de imunofluorescência. Arq Neuro-Psiquiat 46:374–378
Ferreira MS, Nishioka SA, Silvestre MT, Borges AS, Nunes-Araujo FR, Rocha A (1997) Reactivation of Chagas’ disease in patients with AIDS: report of three new cases and review of the literature. Clin Infect Dis 25:1397–1400
Sartori AMC, Shikanai-Yasuda MA, Neto VA, Lopes MH (1998) Follow-up of 18 patients with human immunodeficiency virus (HIV) infection and chronic Chagas’ disease with reactivation of Chagas’ disease causing cardiac disease in three patients. Clin Infect Dis 26:177–179
Rocha A, Ramos Jr AN, Sartori AMC, Correa D, Gontijo ED, Tatto E, Almeida E, Pereira GF, Silva JC, Figueredo JFC, Ferreira MS, Shikanai-Yasuda MA, Pontes RJS, Santos SOS (2006) Recommendations for diagnosis, treatment and management of Trypanosoma cruzi: Human Immunodeficiency Virus (HIV) coinfection. Rev Soc Bras Med Trop 39:92–415
No a l (2006) Recommendations for diagnosis, treatment and follow-up of the Trypanosoma cruzi: human immunodeficiency virus co-infection. Rev Soc Bras Med Trop 39:392–415. [Article in Portuguese]
Brazilian Ministry of Health (2007) Recommendations for diagnosis, treatment and management of Trypanosoma cruzi: human immunodeficiency virus coinfection. Brasília 50 p
Sartori AM, Ibrahim KY, Westphalen EVN, Braz LM, Oliveira OC Jr, Gakiya E, Lopes MH, Shikanai-Yasuda MA (2007) Manifestations of Chagas disease (American trypanosomiasis) in patients with HIV/AIDS. Ann Trop Med Parasitol 101:31–50
Cordova E, Boschi A, Ambrosioni J, Cudos C, Corti M (2008) Reactivation of Chagas disease with central nervous system involvement in HIV-infected patients in Argentina, 1992–2007. Int J Infect Dis 12:587–592
Almeida EA, Ramos Júnior AN, Correia D, Shikanai-Yasuda MA (2011) Co-infection Trypanosoma cruzi/HIV: systematic review (1980–2010). Rev Soc Bras Med Trop 44(6):762–770
Guhl F, Jamillo C, Vallejo GA, Yockteng R, Cardenas-Arroyo F, Forniciari G (1999) Isolation of Trypanosoma cruzi DNA in 4,000 years old mummified human tissue from northern Chile. Am J Physiol Anthropol 108:625–635
Afderheide AC, Salo W, Madden M, Streitz J, Bulkestra J, Guhl F, Arriaza B, Renier C, Wittmers Jr LE, Fornaciari G, Alisson A (2004) A 9,000-years record of Chagas disease. Proc Nat Acad Sci USA 101:2034–2039
Andrade LO, Andrews NW (2005) The Trypanosoma cruzi-host-cell interplay: location, invasion, retention. Nat Rev Microbiol 3:819–823. Bice DE, Zeledón R (1970) Comparison of infectivity of strains of Trypanosoma cruzi. J Parasitol 56:663–670
Lupi O, Bartlett BL, Haugen RN, Dy LC, Sethi A, Klaus SN, Machado Pinto J, Bravo F, Tyring SK (2009) Tropical dermatology: tropical diseases caused by protozoa. J Am Acad Dermatol 60(6):897–925
Coura JR, Borges-Pereira J (2010) Chagas disease: 100 years after its discovery. A systemic review. Acta Trop 115(1–2):5–13
Dias JCP et al (2016) Brazilian consensus on Chagas disease, 2015. Epidemiol. Serv. Saúde [online]25: nspe, 7–86
Vaidian AK, Weiss LM, Tanowitz HB (2004) Chagas’ disease and AIDS. Kinetoplastid Biol Dis 3:2–7
Del Castillo M, Mendoza G, Ovieda J, Perez Bianco RP, Anselmo AE, Silva M (1990) AIDS and Chagas’ disease with central nervous system tumor-like lesion. Am J Med 88:693–694
Gluckstein D, Ciferri F, Ruskin J (1992) Chagas’ disease: another cause of cerebral mass in the acquired immunodeficiency syndrome. Am J Med 92:429–432
Pittella JEH (1993) Central nervous system involvement in Chagas’ disease. An updating. Rev Inst Med Trop São Paulo 35:111–116
Pittella JE (2009) Central nervous system involvement in Chagas disease: a hundred-year-old history. Trans R Soc Trop Med Hyg 103(10):973–978
Rocha A, Oliveira De Meneses AC, DA Silva AM, Ferreira MS, Nishioka SA, Burgarelli MKN, Almeida E, Turcato G Jr, Metze K, Lopes ER (1994) Pathology of patients with Chagas’ disease and acquired immunodeficiency syndrome. Am J Trop Med Hyg 50:261–268
Queiroz AC (1999) Tumor-like lesion of the brain caused by Trypanosoma cruzi. Am J Trop Med Hyg 22:473–476
Yoo TW, Mlikotic A, Cornford ME, Beck CK (2004) Concurrent cerebral American trypanosomiasis and toxoplasmosis in a patient with AIDS. Clin Infect Dis 39(4):e30
Sartori AMC, Lopes MH, Caramelli B, Duarte MIS, Pinto PLDS, Neto VA, Shikanai-Yasuda MA (1995) Simultaneous occurrence of acute myocarditis and reactivated Chagas’ disease in a patient with AIDS. Clin Infect Dis 21:1297–1299
Hemmige V, Tanowitz H, Sethi A (2012) Trypanosoma cruzi infection: a review with emphasis on cutaneous manifestations. Int J Dermatol 51(5):501–508
Scapellato PG, Bottaro EG, Rodriguez-Brieschke MT (2009) Mother-child transmission of Chagas disease: could coinfection with human immunodeficiency virus increase the risk? Rev Soc Bras Med Trop 42:107–109
Freilij H, Altcheh J (1995) Congenital Chagas’ disease: diagnostic and clinical aspects. Clin Infect Dis 21:551–555
Freilij H, Altcheh J, Muchinik G (1995) Perinatal human immunodeficiency virus infection and congenital Chagas’ disease. Pediatr Infect Dis J 14(2):161
Corti M (2000) AIDS and Chagas’ disease. AIDS Patient Care STDs 14:581–588
Montero A, Cohen JE, Martinez DP, Giovannoni AG (1998) Empirical anti-toxoplasma therapy in cerebral AIDS and Chagas disease. Presentation of 2 cases, review of the literature and proposal of an algorithm. Medicina (B Aires) 58:504–506. (Article in Spanish)
Diazgranados CA, Saavedra-Trujillo CH, Mantilla M et al (2009) Chagasic encephalitis in HIV patients: common presentation of an evolving epidemiological and clinical association. Lancet Infect Dis 9:324–330
Luquetti AO, Rassi A (2000) Diagnóstico laboratorial da infecção pelo Trypanosoma cruzi. In: Brener Z, Andrade ZA, Barral-Netto M (eds) Trypanosoma cruzi e CD, 2nd edn. Editora Guanabara Koogan, Rio de Janeiro, pp 344–378
de Freitas VL, da Silva SC, Sartori AM et al (2011) Real-time PCR in HIV/Trypanosoma cruzi coinfection with and without Chagas disease reactivation: association with HIV viral load and CD4 level. PLoS Negl Trop Dis 5:e1277
Kaplan JE, Benson C, Holmes KH et al (2009) Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 58:1–207
Pagano MA, Segura MJ, Di Lorenzo GA, Garau ML, Molina HA, Cahn P et al (1999) Cerebral tumor-like American trypanosomiasis in acquired immunodeficiency syndrome. Ann Neurol 45:403–406
Perez Ramirez L, Barnabé C, Sartori AMC et al (1999) Clinical analysis and parasite genetic diversity in human immunodeficiency virus/Chagas’ disease coinfections in Brazil. Am J Trop Med Hyg 61:198–206
Sartori AMC, Eluf Neto J, Nunes EV, Braz LMA, Caiaffa-Filho HH, Oliveira Jr OC, Amato Neto V, Shikanai-Yasuda MA (2002) Trypanosoma cruzi parasitemia in chronic Chagas disease: comparison between human immunodeficiency virus (HIV)-positive and HIV-negative patients. J Inf Dis 186:872–875
Bern C, Montgomery SP, Herwaldt BL et al (2007) Evaluation and treatment of Chagas disease in the United States: a systematic review. JAMA 298:2171–2181
Almeida EA, Lima JN, Lages-Silva E, Guariento ME, Aoki FH, Torres-Morales AE, Pedro RJ (2010) Chagas’ disease and HIV co-infection in patients without effective antiretroviral therapy: prevalence, clinical presentation and natural history. Trans R Soc Trop Med Hyg 104(7):447–452
Bisio M, Altcheh J, Lattner J, Moscatelli G, Fink V, Burgos JM, Bournissen FG, Schijman AG, Freilij H (2013) Benznidazole treatment of chagasic encephalitis in pregnant woman with AIDS. Emerg Infect Dis 19:1490–1492
Corti M, Yampolsky C (2006) Prolonged survival and immune reconstitution after chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome. Rev Soc Bras Med Trop 39:85–88
López MO (2010) Three-year survival of a patient with HIV and chagasic meningoencephalitis: case report. Rev Chil Infectol 27(2):160–164. [Article in Spanish]
Yasukawa K, Patel SM, Flash CA, Stager CE, Goodman JC, Woc-Colburn L (2014) Trypanosoma cruzi meningoencephalitis in a patient with acquired immunodeficiency syndrome. Am J Trop Med Hyg 91:84–85
Bern C (2012) Chagas disease in the immunosuppressed host. Curr Opin Infect Dis 25:450–457
Perez-Molina JA (2014) Management of Trypanosoma cruzi coinfection in HIV-positive individuals outside endemic areas. Curr Opin Infect Dis 27:9–15
Bice DE, Zeledon R (1970) Comparison of infectivity of strains of trypanosoma cruzi (Chagas, 1909). J Parasitol 56(4):663. doi:10.2307/3277711
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this chapter
Cite this chapter
Eloi-Santos, S.M., Tupinambás, U., Duani, H., Pittella, J.E.H. (2017). Central Nervous System Reactivation of Chagas Disease in Immunocompromised Patients with HIV/AIDS. In: Shapshak, P., et al. Global Virology II - HIV and NeuroAIDS. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-7290-6_25
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7290-6_25
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4939-7288-3
Online ISBN: 978-1-4939-7290-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)